2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$18.80+$0.01 (+0.05%)
Price as of Aug 21, 2026 7:34 PM EDT- $2.0BMarket Cap
- -7.07%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$18.80+$0.01 (+0.05%)
SRPT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.79 | ||
Change | -$0.43 (-2.24%) | ||
Open | $19.39 | ||
High | $19.73 | ||
Low | $18.66 | ||
Previous Close | $19.22 | ||
Volume | 1,674,588 | ||
30-Day Average Volume | 2,907,508 | ||
1-Week Change | 3.81% | ||
1-Month Change | 15.92% | ||
1-Year Change | -7.07% | ||
3-Year Change | -83.48% | ||
5-Year Change | -75.05% | ||
Fundamentals | |||
Shares Outstanding | 105.6M | ||
Total Assets | $3.2B | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $401.3M | ||
Net Income | -$4.9M | ||
Free Cash Flow | $196.5M | ||
EBIT | $19.8M | ||
EBITDA | $30.2M | ||
Net Working Capital | $1.7B | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 75 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | -376 | ||
PEG | 4 | ||
Price/Free Cash Flow | 10 | ||
Price/Operating Cash Flow | 10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue